Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neurodegeneration: From Multiple Sclerosis to Alzheimer’s Disease
Multiple sclerosis in Hispanics: a study of clinical disease expression.
Cognitive Test Analysis May Determine Reliable MS Change Over Time
National MS Society: Sylvia Lawry Physician Fellowships
Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis.
Testosterone treatment in multiple sclerosis: a pilot study.
The natural history of primary progressive MS in British Columbia, Canada.
GlaxoSmithKline Protocol Summaries: Firategrast
IL-17 and Th17 Cells.
Comparison of Switch to Fingolimod or Interferon Beta/Glatiramer Acetate in Active Multiple Sclerosis.
Biogen Idec reports positive top-line results from Phase 2 anti-LINGO-1 trial in people with acute optic neuritis
Gene expression in brain during cuprizone-induced demyelination and remyelination.
The relevance of animal models in multiple sclerosis research.
Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis.
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial.
Sex ratio of multiple sclerosis and clinical phenotype.
Synthetic Biologics Reports UCLA Announcement of Preliminary Positive Topline Efficacy and Safety Results from Investigator-Led Phase II Study of Trimesta™ for RRMS
Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System.
HLA-DRB1*15:01 and multiple sclerosis: a female association?
Environmental, modifiable risk factors for multiple sclerosis
Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study.
Keystone Symposium: Neuroepigenetics
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial.
Clinically isolated syndrome - Rethinking the diagnosis.
T(H)17 cytokines in autoimmune neuro-inflammation.
Pages
« first
‹ previous
…
50
51
52
53
54
55
56
57
58
…
next ›
last »
